Discover the groundbreaking potential of Ramoplanin as a cutting-edge treatment for Neisseria gonorrhoeae infections, a promising advance revealed through meticulous in vitro and in vivo studies in Galleria mellonella.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Ramoplanin as a novel therapy for Neisseria gonorrhoeae infection: an in vitro and in vivo study in Galleria mellonella.
Gestels et al., J Med Microbiol 2024
DOI: 10.1099/jmm.0.001785
New Information: The study introduces ramoplanin as a potential new treatment for gonorrhoea, showing its effectiveness against N. gonorrhoeae.
Importance: With the rise of antimicrobial resistance in N. gonorrhoeae, finding new antibiotics is crucial. This research suggests that ramoplanin could be a viable option.
Contribution to Literature: The study expands the current understanding of gonorrhoea treatment by providing evidence of ramoplanin’s in vitro and in vivo activity against WHO reference strains of N. gonorrhoeae, without observed toxicity in the Galleria mellonella model.